Dihexa
Synthetic peptide studied in animal and cell models for synaptogenic neurotrophic activity and cognitive enhancement at low doses
Last updated: March 1, 2026
- Compound
- Dihexa
- Class
- Cognitive peptide
- Summary
- Synthetic peptide studied in animal and cell models for synaptogenic neurotrophic activity, cognitive enhancement at low doses, oral bioavailability.
- Mechanism
- Dendritic Spine Formation & LTP Enhancement
- Research Status
- Preclinical
- Routes Studied
- Oral or subcutaneous injection
- Evidence Level
- Preclinical-promising · Clinically unproven
What Should You Know About Dihexa?
- What is Dihexa?
- Dihexa is a synthetic peptide studied in animal and cell models for synaptogenic neurotrophic activity and cognitive enhancement at low doses.
- Is Dihexa clinically proven?
- No. Human evidence remains limited and does not establish Dihexa as clinically proven.
- What has Dihexa been studied for?
- Dihexa has been studied in preclinical models of synaptogenic neurotrophic activity, cognitive enhancement at low doses, oral bioavailability. These findings have not been confirmed in large-scale human trials.
- Is Dihexa approved?
- No. Dihexa is not an approved drug and remains a research compound.
What Is Dihexa?
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic hexapeptide analog of angiotensin IV developed by researchers at Washington State University under the direction of Dr. Joseph Harding and Dr. John Wright. It was designed as a stable, metabolically resistant analog of the endogenous hexapeptide Nle1-angiotensin IV, incorporating specific structural modifications to enhance receptor binding potency and oral bioavailability. Dihexa represents one of the most potent nootropic compounds identified in preclinical neuroscience...
Evidence Summary
Dihexa has preliminary preclinical evidence only. Human clinical trial data is not available.
Evidence Breakdown
| Domain | Evidence Level |
|---|---|
| Synaptogenic Neurotrophic Activity | Animal studies |
| Cognitive Enhancement at Low Doses | Animal studies |
| Oral Bioavailability | Animal studies |
| Structural Neuroplasticity Promotion | Animal studies |
| Human clinical evidence | Limited |
| Safety data | Insufficient |
Editorial Position
Dihexa is best understood as a preclinical research compound with promising biological signals but limited human validation. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.
Regulatory Status Snapshot
- Not approved as a therapeutic drug by major regulators
- Safety profile not established in large human populations
Need help interpreting this evidence for your situation?
Talk to a SpecialistA deep research review for Dihexa is not yet available. This compound profile is based on published peer-reviewed references listed below.
Browse all research reviewsWhat Has Dihexa Been Studied For?
Research areas where Dihexa has been investigated in published studies
-
Synaptogenic Neurotrophic Activity Dihexa has been studied in animal models of synaptogenic neurotrophic activity. These findings have not been confirmed in controlled human trials.
-
Cognitive Enhancement at Low Doses Dihexa has been studied in animal models of cognitive enhancement at low doses. These findings have not been confirmed in controlled human trials.
-
Oral Bioavailability Dihexa has been studied in animal models of oral bioavailability. These findings have not been confirmed in controlled human trials.
-
Structural Neuroplasticity Promotion Dihexa has been studied in animal models of structural neuroplasticity promotion. These findings have not been confirmed in controlled human trials.
How Does Dihexa Work?
These mechanisms have been observed in preclinical models. They are plausible but have not been linked to proven clinical outcomes in humans.
- 01 Receptor interaction
- 02 Intracellular signaling
- 03 Downstream biological effect
- 04 Synaptogenic Gene Expression
Not sure if Dihexa is right for you?
A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about Dihexa.
Community Reports (Anecdotal)
Experiences shared here are self-reported and do not represent clinical evidence.
Rate Dihexa
How Is Dihexa Administered?
Dihexa is available via Oral or subcutaneous injection. Appropriate use and protocol should be determined by a qualified specialist.
What Are the Specifications of Dihexa?
What Conditions Has Dihexa Been Linked To?
Have Questions About Dihexa?
Yes. Unlike most peptide-based compounds that require injection due to gastrointestinal degradation, Dihexa demonstrates oral bioavailability. Its modified structure incorporating lipophilic hexanoic acid groups enables gastrointestinal absorption and blood-brain barrier penetration.
Dihexa remains in preclinical research stages. Published studies have been conducted primarily in rodent models, demonstrating cognitive-enhancing effects in spatial learning and memory paradigms. The compound has not entered formal human clinical trials.
Published studies on Dihexa can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.
Ready to discuss Dihexa with a specialist?
Get evidence-based guidance tailored to your health goals and medical context.
Book a Consultation Free initial consultation. No obligation.Reviewed by the Peptide Science Thailand Editorial Team.
Last reviewed: March 1, 2026